Implementation of the Physical Agents (Electromagnetic Fields) Directive 2004/40/EC in all Member States could effectively halt the use of magnetic resonance imaging (MRI), an important tool in cancer diagnosis, treatment, and research, a scientist told a press conference at the European Cancer Conference (ECCO 14) today (Monday September 24). The Directive is due to be implemented across Europe by April 2008.
Growth hormone and associated proteins could be responsible for promoting many types of cancer, including breast and prostate cancer, according to an Australian researcher.
Anti-cancer treatments often effectively shrink the size of tumors, but some might have an opposite effect, actually expanding the small population of cancer stem cells believed to drive the disease, according to findings presented Sept. 19 by Vasyl Vasko, M.D. Ph.D., a pathologist at the Uniformed Services University of the Health Sciences (USU) at the American Association for Cancer Research’s second International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
Researchers at UT Southwestern Medical Center have found nearly 350 genes related to female fertility. Their research may open the door to much wider study in the poorly understood field of infertility.
National Jewish Medical and Research Center discharged Robert Daniels, the multi-drug-resistant tuberculosis patient who came to the center from Arizona, today at 11 a.m. Daniels was scheduled to take a commercial airplane flight back to Phoenix this afternoon escorted by a private security guard hired by Maricopa County Public Health Department in Arizona.
The lack of thorough and reliable clinical data on the way medicines affect children requires strengthened safety monitoring and vigilance of medicinal products. This is the fundamental message of Promoting safety of medicines for children, released today by the World Health Organization (WHO).
In an 18-year-study on attention-deficit/hyperactivity disorder (AD/HD), Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with AD/HD.
As many as one in four people in westernized countries experience pain or discomfort in their upper abdomen, and physicians have almost nothing to offer except anti-acid medicines, which usually don’t work. Now, in a small but novel study, researchers have found evidence that an abnormal amount of inflammatory cells populates the upper intestine of affected individuals, which suggests a fresh way of understanding the common complaint.
The North Central Cancer Treatment Group (NCCTG), a clinical research group based at Mayo Clinic, has received a $34.4 million renewal grant from the National Cancer Institute (NCI). The grant, to be awarded over a six-year period, will help fund NCCTG’s efforts to develop and conduct clinical trials to test new cancer therapies.
Eli Lilly and Company announced that it has submitted an application with the European Medicines Agency (EMEA) for centralised review of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, for the first-line treatment of advanced non-small cell lung cancer (NSCLC).